Cognitive Impairment in Pediatric Onset Multiple Sclerosis
36 participantsStarted 2015-09-15
Plain-language summary
Computer-assisted rehabilitation of attention deficits in pediatric Multiple Sclerosis and ADHD patients recruited during the study "Cognitive impairment in Pediatric Onset Multiple Sclerosis: research of biomarkers predictive of cognitive impairment progression".
Who can participate
Age range17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* POMS diagnosed according to the most recent diagnostic criteria;
* age \<18 years;
* Expanded Disability Status Scale (EDSS) score ≤5.5;
* impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values;
* ADHD patients with the subtype inattention;
* ADHD diagnosis performed according the DSM-5 criteria and the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention- Deficit/Hyperactivity Disorder (MTA) - Swanson, Nolan, and Pelham IV Rating Scale (MTA-SNAP-IV), Conner's Parent Rating Scale Revised (CPRS-R), Conner's Teacher Rating Scale Revised (CTRS-R), Child Behavior Checklist (CBCL), Kiddie Schedule for Affective Disorder and Schizophrenia (K-SADS);
* age \<18 years;
* impairment on at least 2/4 attention tests defined as scores \<1.5 standard deviation (SD) of normative values;
Exclusion Criteria:
* severe cognitive impairment (performance ≤2.0 SD of normative values);
* severe visual loss (unable to read Times New Roman font 16 with the best correction);
* major psychiatric illness;
* alcohol or substance abuse;
* education \<5 years;
* previous cognitive rehabilitation training;
* ongoing relapse or steroid treatment during the 30 days preceding enrollment;
* ADHD subtype hyperactivity;
* previously exposure or treatment with any psychotropic drug.
What they're measuring
1
to evaluate the effect of the cognitive training on neuropsychological performances.